London stocks were still sharply lower by midday on Thursday as Donald Trump’s more aggressive than expected tariff ...
GSK has had another setback in its oncology ... the new head of US human pharma at Boehringer Ingelheim. The ISPE Singapore Affiliate Conference & Exhibition is one of the largest and most ...
GSK also acquire a further meningitis candidate ... the new head of US human pharma at Boehringer Ingelheim. The ISPE Singapore Affiliate Conference & Exhibition is one of the largest and most ...
A major British investor is exploring a potential rescue plan for 23andMe, after the company filed for bankrupcy protection ...
The US president announces a 10% tariff on all imports, with further measures targeting countries the White House call the ...
Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...
GSK has three segments: Specialty Medicines (HIV, Oncology, Immunology/Respiratory and Other), Vaccines (Meningitis, Influenza, Shingles, RSV and Established Vaccines) and General Medicines ...
In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other best ADR stocks. American Depositary Receipts (ADR) are US-listed securities that represent shares ...
Keir Starmer warned of an 'economic impact' from Donald Trump's extraordinary trade war today with tens of thousands of ...
GSK Trading Up 0.6 % GSK stock opened at $38.74 on Friday. The company has a current ratio of 0.78, a quick ratio of 0.52 and a debt-to-equity ratio of 1.12. The company has a market ...
GSK (LON:GSK – Get Free Report)‘s stock had its “underweight” rating reaffirmed by equities research analysts at JPMorgan Chase & Co. in a report issued on Friday, Marketbeat Ratings reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback